TRETTEN
Coagulation Factor XIII A-Subunit (Recombinant) · KIT · Novo Nordisk
TRETTEN is a kit containing coagulation factor xiii a-subunit (recombinant). Manufactured by Novo Nordisk.
Key Facts
- Brand Name
- TRETTEN
- Generic Name
- Coagulation Factor XIII A-Subunit (Recombinant)
- NDC Code (Product)
0169-7013- Manufacturer
- Novo Nordisk
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125398
- Marketing Start
- 12/23/2013
Recall History
No Recall HistoryFrequently Asked Questions
What is TRETTEN used for?
TRETTEN contains Coagulation Factor XIII A-Subunit (Recombinant). It is a kit taken as directed. Consult your doctor for specific uses.
Is TRETTEN a controlled substance?
TRETTEN is not classified as a controlled substance by the DEA.
What is the generic name for TRETTEN?
The generic name for TRETTEN is Coagulation Factor XIII A-Subunit (Recombinant). There are no other listed brand versions of Coagulation Factor XIII A-Subunit (Recombinant).
What is the NDC code for TRETTEN ?
The NDC (National Drug Code) for TRETTEN is 0169-7013, listed by Novo Nordisk.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)